BIOMAT Database Logo BIOMAT Database Logo

Regulation of lipoprotein lipase synthesis in 3T3-L1 adipocytes by interleukin-11/adipogenesis inhibitory factor. 1994

J Ohsumi, and K Miyadai, and I Kawashima, and S Sakakibara, and J Yamaguchi, and Y Itoh
Biomedical Laboratories, Sankyo Co., Ltd., Tokyo, Japan.

Interleukin-11/adipogenesis inhibitory factor (IL-11/AGIF) inhibits adipogenesis and suppresses lipoprotein lipase (EC3.1.1.34, LPL) activity in adipocytes (1,2). We investigated the mechanism of suppression of LPL activity in 3T3-L1 adipocytes by IL-11/AGIF. Incubation of adipocytes with 50 ng/ml of IL-11/AGIF led to a 75% decrease in LPL activity within 8 hours, whereas LPL mRNA level decreased by less than 30%. The LPL synthesis, as judged by the incorporation of 35S-label into immunoprecipitable LPL, decreased at almost the same rate over the same time period as enzyme activity. The degradation rate was not significantly affected by IL-11/AGIF. These data suggest that regulation of the synthesis of the enzyme protein is at least one of the main steps in the suppression of LPL by IL-11/AGIF in 3T3-L1 adipocytes.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008071 Lipoprotein Lipase An enzyme of the hydrolase class that catalyzes the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. The enzyme hydrolyzes triacylglycerols in chylomicrons, very-low-density lipoproteins, low-density lipoproteins, and diacylglycerols. It occurs on capillary endothelial surfaces, especially in mammary, muscle, and adipose tissue. Genetic deficiency of the enzyme causes familial hyperlipoproteinemia Type I. (Dorland, 27th ed) EC 3.1.1.34. Heparin-Clearing Factor,Lipemia-Clearing Factor,Diacylglycerol Lipase,Diglyceride Lipase,Post-Heparin Lipase,Postheparin Lipase,Postheparin Lipoprotein Lipase,Factor, Heparin-Clearing,Factor, Lipemia-Clearing,Heparin Clearing Factor,Lipase, Diacylglycerol,Lipase, Diglyceride,Lipase, Lipoprotein,Lipase, Post-Heparin,Lipase, Postheparin,Lipase, Postheparin Lipoprotein,Lipemia Clearing Factor,Lipoprotein Lipase, Postheparin,Post Heparin Lipase
D008715 Methionine A sulfur-containing essential L-amino acid that is important in many body functions. L-Methionine,Liquimeth,Methionine, L-Isomer,Pedameth,L-Isomer Methionine,Methionine, L Isomer
D002454 Cell Differentiation Progressive restriction of the developmental potential and increasing specialization of function that leads to the formation of specialized cells, tissues, and organs. Differentiation, Cell,Cell Differentiations,Differentiations, Cell
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor
D015870 Gene Expression The phenotypic manifestation of a gene or genes by the processes of GENETIC TRANSCRIPTION and GENETIC TRANSLATION. Expression, Gene,Expressions, Gene,Gene Expressions
D016475 3T3 Cells Cell lines whose original growing procedure consisted being transferred (T) every 3 days and plated at 300,000 cells per plate (J Cell Biol 17:299-313, 1963). Lines have been developed using several different strains of mice. Tissues are usually fibroblasts derived from mouse embryos but other types and sources have been developed as well. The 3T3 lines are valuable in vitro host systems for oncogenic virus transformation studies, since 3T3 cells possess a high sensitivity to CONTACT INHIBITION. 3T3 Cell,Cell, 3T3,Cells, 3T3

Related Publications

J Ohsumi, and K Miyadai, and I Kawashima, and S Sakakibara, and J Yamaguchi, and Y Itoh
Regulation of lipoprotein lipase synthesis and 3T3-L1 adipocyte metabolism by recombinant interleukin 1.
December 1986, Biochimica et biophysica acta,
J Ohsumi, and K Miyadai, and I Kawashima, and S Sakakibara, and J Yamaguchi, and Y Itoh
Regulation of lipoprotein lipase synthesis in 3T3-L1 adipocytes by cachectin. Further proof for identity with tumour necrosis factor.
December 1986, The Biochemical journal,
J Ohsumi, and K Miyadai, and I Kawashima, and S Sakakibara, and J Yamaguchi, and Y Itoh
Interleukin 11 signaling in 3T3-L1 adipocytes.
January 2005, Journal of cellular physiology,
J Ohsumi, and K Miyadai, and I Kawashima, and S Sakakibara, and J Yamaguchi, and Y Itoh
Transcriptional regulation of the human lipoprotein lipase gene in 3T3-L1 adipocytes.
October 1991, The Journal of biological chemistry,
J Ohsumi, and K Miyadai, and I Kawashima, and S Sakakibara, and J Yamaguchi, and Y Itoh
Ginsenosides increase secretion of lipoprotein lipase by 3T3-L1 adipocytes.
December 1996, Bioscience, biotechnology, and biochemistry,
J Ohsumi, and K Miyadai, and I Kawashima, and S Sakakibara, and J Yamaguchi, and Y Itoh
Characterization of differentiation factor/leukaemia inhibitory factor effect on lipoprotein lipase activity and mRNA in 3T3-L1 adipocytes.
July 1994, Cytokine,
J Ohsumi, and K Miyadai, and I Kawashima, and S Sakakibara, and J Yamaguchi, and Y Itoh
Regulation of lipoprotein lipase synthesis by recombinant tumor necrosis factor--the primary regulatory role of the hormone in 3T3-L1 adipocytes.
December 1986, Archives of biochemistry and biophysics,
J Ohsumi, and K Miyadai, and I Kawashima, and S Sakakibara, and J Yamaguchi, and Y Itoh
Characterization of lipoprotein lipase storage vesicles in 3T3-L1 adipocytes.
March 2022, Journal of cell science,
J Ohsumi, and K Miyadai, and I Kawashima, and S Sakakibara, and J Yamaguchi, and Y Itoh
The Inhibitory Effects of Juglanin on Adipogenesis in 3T3-L1 Adipocytes.
January 2020, Drug design, development and therapy,
J Ohsumi, and K Miyadai, and I Kawashima, and S Sakakibara, and J Yamaguchi, and Y Itoh
Effect of Acanthopanax senticosus on lipoprotein lipase in 3T3-L1 adipocytes.
February 2004, Phytotherapy research : PTR,
Copied contents to your clipboard!